Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

34 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Defining genetic risk factors for scleroderma-associated interstitial lung disease : IRF5 and STAT4 gene variants are associated with scleroderma while STAT4 is protective against scleroderma-associated interstitial lung disease.
Stock CJW, De Lauretis A, Visca D, Daccord C, Kokosi M, Kouranos V, Margaritopoulos G, George PM, Molyneaux PL, Nihtyanova S, Chua F, Maher TM, Ong V, Abraham DJ, Denton CP, Wells AU, Wain LV, Renzoni EA. Stock CJW, et al. Among authors: de lauretis a. Clin Rheumatol. 2020 Apr;39(4):1173-1179. doi: 10.1007/s10067-019-04922-6. Epub 2020 Jan 8. Clin Rheumatol. 2020. PMID: 31916109 Free PMC article.
Serum markers of pulmonary epithelial damage in systemic sclerosis-associated interstitial lung disease and disease progression.
Stock CJW, Hoyles RK, Daccord C, Kokosi M, Visca D, De Lauretis A, Alfieri V, Kouranos V, Margaritopoulos G, George PM, Molyneaux PL, Chua F, Maher TM, Abraham DJ, Ong V, Donovan J, Sestini P, Denton CP, Wells AU, Renzoni EA. Stock CJW, et al. Among authors: de lauretis a. Respirology. 2021 May;26(5):461-468. doi: 10.1111/resp.13988. Epub 2020 Dec 17. Respirology. 2021. PMID: 33336433
Rituximab in severe, treatment-refractory interstitial lung disease.
Keir GJ, Maher TM, Ming D, Abdullah R, de Lauretis A, Wickremasinghe M, Nicholson AG, Hansell DM, Wells AU, Renzoni EA. Keir GJ, et al. Among authors: de lauretis a. Respirology. 2014 Apr;19(3):353-9. doi: 10.1111/resp.12214. Epub 2013 Nov 29. Respirology. 2014. PMID: 24286447
Predicting Outcomes in Idiopathic Pulmonary Fibrosis Using Automated Computed Tomographic Analysis.
Jacob J, Bartholmai BJ, Rajagopalan S, van Moorsel CHM, van Es HW, van Beek FT, Struik MHL, Kokosi M, Egashira R, Brun AL, Nair A, Walsh SLF, Cross G, Barnett J, de Lauretis A, Judge EP, Desai S, Karwoski R, Ourselin S, Renzoni E, Maher TM, Altmann A, Wells AU. Jacob J, et al. Among authors: de lauretis a. Am J Respir Crit Care Med. 2018 Sep 15;198(6):767-776. doi: 10.1164/rccm.201711-2174OC. Am J Respir Crit Care Med. 2018. PMID: 29684284 Free PMC article.
Pleuroparenchymal fibroelastosis in systemic sclerosis: prevalence and prognostic impact.
Bonifazi M, Sverzellati N, Negri E, Jacob J, Egashira R, Moser J, Piciucchi S, Mei F, De Lauretis A, Visca D, Goh N, Bonini M, Cirilli L, La Vecchia C, Chua F, Kouranos V, Margaritopoulos G, Kokosi M, Maher TM, Gasparini S, Gabrielli A, Wells AU, Renzoni EA. Bonifazi M, et al. Among authors: de lauretis a. Eur Respir J. 2020 Jul 9;56(1):1902135. doi: 10.1183/13993003.02135-2019. Print 2020 Jul. Eur Respir J. 2020. PMID: 32299855 Free PMC article.
Ambulatory oxygen in interstitial lung disease.
Visca D, Montgomery A, de Lauretis A, Sestini P, Soteriou H, Maher TM, Wells AU, Renzoni EA. Visca D, et al. Among authors: de lauretis a. Eur Respir J. 2011 Oct;38(4):987-90. doi: 10.1183/09031936.00190710. Eur Respir J. 2011. PMID: 21965506 Free article. No abstract available.
34 results